Andrea Sobrio, founder of Executive Insight, on why patient referral networks are critical for pharma success.
Andrea Sobrio, founder of Executive Insight, on why patient referral networks are critical for pharma success.
For patients, healthcare ultimately comes down to decisions; decisions about when to reach out for help, which doctor to see, what treatment to follow, and how long to adhere to a medication. As healthcare has evolved, this decision-making process has grown increasingly complex, with more doctors, experts, procedures, and drugs to wade through.
Its no surprise, then, that understanding and collaborating with patient referral networksthe groups of experts best positioned to diagnose, treat, and manage patients within given therapeutic areashave become critical for pharmaceutical companies to succeed, says Andrea Sobrio, founder of Executive Insight.
Sobrio, who for the past 10 years has focused on helping pharmaceutical companies improve and transform their commercial operations to become more customer-centric, will present on the subject of patient referral networks at eyeforpharmas 8th annual Sales Force Effectiveness summit in Barcelona from April 27th through the 29th.
Sobrio spoke with eyeforpharma ahead of the summit for a sneak preview of his talk, and you can listen to her podcast here.
Andrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs